Clinical Trials
5 trialsNCT06120140 2026-06-05
COCOON
Janssen Research & Development, LLC
Phase 2 Active not recruiting
NCT05741164 2026-06-04
Propranolol and Pembrolizumab for Tumor Re-sensitization and Treatment of Patients With Checkpoint Inhibitor Refractory Metastatic or Unresectable Triple Negative Breast Cancer
Emory University
Phase 2 Recruiting
NCT02104011 2026-05-19
STBETA
University Hospital, Bordeaux
Phase 2 Completed
NCT07549906 2026-04-24
Neoadjuvant Iparomlimab/Tuvonralimab Plus CAPEOX Versus Iparomlimab/Tuvonralimab Plus CAPEOX and Propranolol for Locally Advanced pMMR Colon Cancer: A Prospective, Single-Center, Multi-Cohort Study
Sun Yat-sen University
Phase 2 Not yet recruiting
NCT06445166 2026-04-06
Propranolol for the Treatment of Kaposi Sarcoma in Adults
Washington University School of Medicine
Phase 2 Recruiting